Mycobacterium smegmatis 607 is a facultative anaerobe, Gram-positive, rod-shaped human pathogen that was isolated from Human.
Gram-positive rod-shaped facultative anaerobe human pathogen 16S sequence Bacteria| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Actinomycetota |
| Class Actinomycetes |
| Order Mycobacteriales |
| Family Mycobacteriaceae |
| Genus Mycobacterium |
| Species Mycobacterium smegmatis |
| Full scientific name Mycobacterium smegmatis (Trevisan 1889) Lehmann and Neumann 1899 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Gram stain | Cell shape | Motility | |
|---|---|---|---|---|
| 122644 | positive | rod-shaped |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 11040 | MIDDLEBROOK MEDIUM (DSMZ Medium 645) | Medium recipe at MediaDive | Name: MIDDLEBROOK MEDIUM (DSMZ Medium 645) Composition: Bacto Middlebrook 7H10 agar 20.9945 g/l Glycerol Distilled water | ||
| 36869 | MEDIUM 55 - for Mycobacterium | ||||
| 122644 | CIP Medium 72 | Medium recipe at CIP | |||
| 122644 | CIP Medium 55 | Medium recipe at CIP |
| 122644 | Oxygen tolerancefacultative anaerobe |
| 67770 | ObservationAssay of Antibiotics (Japanese Pharmacopoeia, 14 ed.) |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 68382 | alkaline phosphatase | - | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 68382 | beta-glucosidase | + | 3.2.1.21 | from API zym |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 122644 | catalase | + | 1.11.1.6 | |
| 68382 | cystine arylamidase | + | 3.4.11.3 | from API zym |
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 68382 | lipase (C 14) | + | from API zym | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 122644 | oxidase | - | ||
| 68382 | trypsin | + | 3.4.21.4 | from API zym |
| 122644 | urease | + | 3.5.1.5 | |
| 68382 | valine arylamidase | + | from API zym |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 20218 | Mycolicibacterium smegmatis sequence | AH000830 | 204 | 1772 |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Pathogenicity | Semisynthetic Derivatives of Selected Amaryllidaceae Alkaloids as a New Class of Antimycobacterial Agents. | Maafi N, Mamun AA, Jandourek O, Marikova J, Breiterova K, Diepoltova A, Konecna K, Hostalkova A, Hulcova D, Kunes J, Kohelova E, Koutova D, Safratova M, Novakova L, Cahlikova L. | Molecules | 10.3390/molecules26196023 | 2021 | |
| 5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation. | Ambrozkiewicz W, Kucerova-Chlupacova M, Jandourek O, Konecna K, Paterova P, Barta P, Vinsova J, Dolezal M, Zitko J. | Molecules | 10.3390/molecules25071561 | 2020 | ||
| Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity. | Bouz G, Semelkova L, Jandourek O, Konecna K, Paterova P, Navratilova L, Kubicek V, Kunes J, Dolezal M, Zitko J. | Molecules | 10.3390/molecules24071212 | 2019 | ||
| Pathogenicity | Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors. | Bouz G, Juhas M, Niklova P, Jandourek O, Paterova P, Janousek J, Tumova L, Kovalikova Z, Kastner P, Dolezal M, Zitko J. | Molecules | 10.3390/molecules22101797 | 2017 | |
| Pathogenicity | N-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents-The Synthesis and Biological Evaluation of Enantiomers. | Juhas M, Kucerova L, Horacek O, Jandourek O, Kubicek V, Konecna K, Kucera R, Barta P, Janousek J, Paterova P, Kunes J, Dolezal M, Zitko J. | Molecules | 10.3390/molecules25071518 | 2020 | |
| Diosgenin ameliorates silica-induced tuberculosis in rats. | Adu WA, Ativui S, Ofori M, Owusu G, Danquah CA, Poku Sampene Ossei P. | Animal Model Exp Med | 10.1002/ame2.70055 | 2025 | ||
| Targeting mycobacterial transpeptidases: evaluating the roles of Ldt and PBP inhibition in suppressing Mycobacterium smegmatis. | de Munnik M, Calvopina K, Rabe P, Schofield CJ. | Antimicrob Agents Chemother | 10.1128/aac.00126-25 | 2025 | ||
| Regulating white blood cell activity through the novel universal receptive system. | Tetz V, Kardava K, Vecherkovskaya M, Khodadadi-Jamayran A, Tsirigos A, Tetz G. | Sci Rep | 10.1038/s41598-025-21866-x | 2025 | ||
| Regulatory mechanism of the SenX3-RegX3 two-component system in Mycobacterium smegmatis: Roles of PhoU in sensing inorganic phosphate levels. | Seung Y, Baik HE, Park EJ, Oh JI. | J Biol Chem | 10.1016/j.jbc.2025.110435 | 2025 | ||
| New Streptomyces-Derived Antibacterial Compounds Targeting Gram-Positive Bacteria: A Systematic Review. | Ait Assou S, El Hassouni M. | ScientificWorldJournal | 10.1155/tswj/6659874 | 2025 | ||
| Oligohexamethylene Guanidine Derivative as a Means to Prevent Biological Fouling of a Polymer-Based Composite Optical Oxygen Sensor. | Lisowski MD, Korobova EV, Naumova AO, Sedishev IP, Markova AA, Nguyen MT, Kuzmin VA, Nichugovskiy AI, Arlyapov VA, Yashtulov NA, Melnikov PV. | Polymers (Basel) | 10.3390/polym15234508 | 2023 | ||
| Enzymology | Efficacious Extraction and Purification Technique of a Potential Antimycobacterial Bacteriocin Produced by Bacillus subtilis (MK733983) of Ethnomedicinal Origin. | Sudha SS, Aranganathan V. | Indian J Microbiol | 10.1007/s12088-023-01128-y | 2023 | |
| The Garlic Tree of Borneo, Scorodocarpus borneensis (Baill.) Becc. (Olacaceae): Potential Utilization in Pharmaceutical, Nutraceutical, and Functional Cosmetic Industries. | Wiart C, Shorna AA, Rahmatullah M, Nissapatorn V, Seelan JSS, Rahman H, Rusdi NA, Mustaffa N, Elbehairy L, Sulaiman M. | Molecules | 10.3390/molecules28155717 | 2023 | ||
| Crude extracts activity of three selected medicinal plants from the Venda region against some pathogenic organisms. | Mabadahanye K, Bhembe NL, Green E. | Afr Health Sci | 10.4314/ahs.v22i2.81 | 2022 | ||
| Rel-dependent decrease in the expression of ribosomal protein genes by inhibition of the respiratory electron transport chain in Mycobacterium smegmatis. | Kim NK, Baek JE, Lee YJ, Oh Y, Oh JI. | Front Microbiol | 10.3389/fmicb.2024.1448277 | 2024 | ||
| Neogrisemycin, a Trisulfide-Bridged Angucycline, Produced upon Expressing the Thioangucycline Biosynthetic Gene Cluster in Streptomyces albus J1074. | Cao M, Yang D, Adhikari A, Ye F, Zheng C, Yan W, Meng S, Su P, Shen B. | Org Lett | 10.1021/acs.orglett.2c04303 | 2023 | ||
| Comparing the biological properties and chemical profiling of chestnut bee pollen and bee bread collected from Anatolia. | Sonmez E, Kekecoglu M, Sahin H, Bozdeveci A, Karaoglu SA. | Braz J Microbiol | 10.1007/s42770-023-00980-w | 2023 | ||
| Comparative Evaluation of the Antibacterial and Antitumor Activities of Marine Alkaloid 3,10-Dibromofascaplysin. | Zhidkov ME, Smirnova PA, Grammatikova NE, Isakova EB, Shchekotikhin AE, Styshova ON, Klimovich AA, Popov AM. | Mar Drugs | 10.3390/md23020068 | 2025 | ||
| Antimicrobial effects of syndiotactic polypeptides. | Hazam PK, Phukan C, Akhil R, Singh A, Ramakrishnan V. | Sci Rep | 10.1038/s41598-021-81394-2 | 2021 | ||
| Genetics | Strategies Used for the Discovery of New Microbial Metabolites with Antibiotic Activity. | Dasi-Delgado P, Andreu C, Del Olmo ML. | Molecules | 10.3390/molecules30132868 | 2025 | |
| A Novel Approach of Targeting Linezolid Nanoemulsion for the Management of Lymph Node Tuberculosis. | Choudhary A, Jain P, Mohapatra S, Mustafa G, Ansari MJ, Aldawsari MF, Alalaiwe AS, Mirza MA, Iqbal Z. | ACS Omega | 10.1021/acsomega.2c00592 | 2022 | ||
| Pathogenicity | Genetic dissection of the degradation pathways for the mycotoxin fusaric acid in Burkholderia ambifaria T16. | Vinacour M, Moiana M, Forne I, Jung K, Bertea M, Calero Valdayo PM, Nikel PI, Imhof A, Palumbo MC, Fernandez Do Porto D, Ruiz JA. | Appl Environ Microbiol | 10.1128/aem.00630-23 | 2023 | |
| Phylogeny | Diversity and Antimicrobial Activity of Culturable Fungal Endophytes in Solanum mauritianum. | Pelo S, Mavumengwana V, Green E. | Int J Environ Res Public Health | 10.3390/ijerph17020439 | 2020 | |
| TBAJ-587, a novel diarylquinoline, is active against Mycobacterium abscessus. | Fan J, Tan Z, He S, Li A, Jia Y, Li J, Zhang Z, Li B, Chu H. | Antimicrob Agents Chemother | 10.1128/aac.00945-24 | 2024 | ||
| Culture of Mycobacterium smegmatis in Different Carbon Sources to Induce In Vitro Cholesterol Consumption Leads to Alterations in the Host Cells after Infection: A Macrophage Proteomics Analysis. | de Lima JB, da Silva Fonseca LP, Xavier LP, de Matos Macchi B, Cassoli JS, da Silva EO, da Silva Valadares RB, do Nascimento JLM, Santos AV, de Sena CBC. | Pathogens | 10.3390/pathogens10060662 | 2021 | ||
| Silver(I)-Tazobactam Frameworks with Improved Antimicrobial Activity. | Ferreira DR, Alves PC, Kirillov AM, Rijo P, Andre V. | Front Chem | 10.3389/fchem.2021.815827 | 2021 | ||
| Combating Intracellular Pathogens with Nanohybrid-Facilitated Antibiotic Delivery. | Bose RJC, Tharmalingam N, Choi Y, Madheswaran T, Paulmurugan R, McCarthy JR, Lee SH, Park H. | Int J Nanomedicine | 10.2147/ijn.s271850 | 2020 | ||
| Human Neutrophil Granule Exocytosis in Response to Mycobacterium smegmatis. | Miralda I, Klaes CK, Graham JE, Uriarte SM. | Pathogens | 10.3390/pathogens9020123 | 2020 | ||
| Perspectives of aminoacylases in biocatalytic synthesis of N-acyl-amino acids surfactants. | Haeger G, Wirges J, Bongaerts J, Schorken U, Siegert P. | Appl Microbiol Biotechnol | 10.1007/s00253-024-13328-7 | 2024 | ||
| Loureirin A is a narrow-spectrum antimicrobial agent against Helicobacter pylori. | Tong Q, Yin C, Hang X, Bai Y, Zhang C, Xu J, Huang Y, Ge Y, Chen T, Zeng L, Jia J, Bi H. | Antimicrob Agents Chemother | 10.1128/aac.00314-24 | 2024 | ||
| Genetics | Characterization and Genomic Analysis of Escherichia coli O157:H7 Phage UAE_MI-01 Isolated from Birds. | Sultan-Alolama MI, Amin A, El-Tarabily KA, Vijayan R. | Int J Mol Sci | 10.3390/ijms232314846 | 2022 | |
| New Antimicrobial Phenyl Alkenoic Acids Isolated from an Oil Palm Rhizosphere-Associated Actinomycete, Streptomyces palmae CMU-AB204T. | Sujarit K, Mori M, Dobashi K, Shiomi K, Pathom-Aree W, Lumyong S. | Microorganisms | 10.3390/microorganisms8030350 | 2020 | ||
| Antimicrobial Activity of Pyrazinamide Coordination Frameworks Synthesized by Mechanochemistry. | Quaresma S, Alves PC, Rijo P, Duarte MT, Andre V. | Molecules | 10.3390/molecules26071904 | 2021 | ||
| Re-sensitization of Mycobacterium smegmatis to Rifampicin Using CRISPR Interference Demonstrates Its Utility for the Study of Non-essential Drug Resistance Traits. | Faulkner V, Cox AA, Goh S, van Bohemen A, Gibson AJ, Liebster O, Wren BW, Willcocks S, Kendall SL. | Front Microbiol | 10.3389/fmicb.2020.619427 | 2020 | ||
| Genetics | Isolation, Characterization, and Comparative Genomic Analysis of Bacteriophage Ec_MI-02 from Pigeon Feces Infecting Escherichia coli O157:H7. | Sultan-Alolama MI, Amin A, Vijayan R, El-Tarabily KA. | Int J Mol Sci | 10.3390/ijms24119506 | 2023 | |
| Metabolism | Experimental elucidation of an antimycobacterial bacteriocin produced by ethnomedicinal plant-derived Bacillus subtilis (MK733983). | Santhi Sudha S, Aranganathan V. | Arch Microbiol | 10.1007/s00203-020-02173-7 | 2021 | |
| Nigella damascena L. Essential Oil-A Valuable Source of beta-Elemene for Antimicrobial Testing. | Sieniawska E, Sawicki R, Golus J, Swatko-Ossor M, Ginalska G, Skalicka-Wozniak K. | Molecules | 10.3390/molecules23020256 | 2018 | ||
| Metabolism | Microenvironment of Mycobacterium smegmatis Culture to Induce Cholesterol Consumption Does Cell Wall Remodeling and Enables the Formation of Granuloma-Like Structures. | Dos Santos ACD, Marinho VHS, Silva PHA, Macchi BM, Arruda MSP, da Silva EO, do Nascimento JLM, do Nascimento JLM, de Sena CBC. | Biomed Res Int | 10.1155/2019/1871239 | 2019 | |
| Pathogenicity | Stereocalpin B, a New Cyclic Depsipeptide from the Antarctic Lichen Ramalina terebrata. | Lee S, Jeong SY, Nguyen DL, So JE, Kim KH, Kim JH, Han SJ, Suh SS, Lee JH, Youn UJ. | Metabolites | 10.3390/metabo12020141 | 2022 | |
| Metabolism | The Mycobacteriophage Ms6 LysB N-Terminus Displays Peptidoglycan Binding Affinity. | Gigante AM, Olivenca F, Catalao MJ, Leandro P, Moniz-Pereira J, Filipe SR, Pimentel M. | Viruses | 10.3390/v13071377 | 2021 | |
| Berberine and its nanoformulations and extracts: potential strategies and future perspectives against multi-drug resistant bacterial infections. | Yang X, Wang Y, Li L, Tang D, Yan Z, Li M, Jiang J, Bi D. | Front Microbiol | 10.3389/fmicb.2025.1643409 | 2025 | ||
| Comparison Study of Different Extracts of Plectranthus madagascariensis, P. neochilus and the Rare P. porcatus (Lamiaceae): Chemical Characterization, Antioxidant, Antimicrobial and Cytotoxic Activities. | Matias D, Nicolai M, Fernandes AS, Saraiva N, Almeida J, Saraiva L, Faustino C, Diaz-Lanza AM, Reis CP, Rijo P. | Biomolecules | 10.3390/biom9050179 | 2019 | ||
| Enzymology | Bioactive Pyridone Alkaloids from a Deep-Sea-Derived Fungus Arthrinium sp. UJNMF0008. | Bao J, Zhai H, Zhu K, Yu JH, Zhang Y, Wang Y, Jiang CS, Zhang X, Zhang Y, Zhang H. | Mar Drugs | 10.3390/md16050174 | 2018 | |
| Phylogeny | Recent advances in the structures and bioactivities of benzopyrans derived from marine fungi: a review. | Xi Y, Wang H, Sun L, Ma X, Zhang S, Zhang Z. | Front Pharmacol | 10.3389/fphar.2024.1482316 | 2024 | |
| Phytochemical analysis and anti-infective potential of fungal endophytes isolated from Nigella sativa seeds. | Shady NH, Sobhy SK, Mostafa YA, Yahia R, Glaeser SP, Kampfer P, El-Katatny MH, Abdelmohsen UR. | BMC Microbiol | 10.1186/s12866-023-03085-4 | 2023 | ||
| Biotechnology | Bright Side of Fusarium oxysporum: Secondary Metabolites Bioactivities and Industrial Relevance in Biotechnology and Nanotechnology. | Ibrahim SRM, Sirwi A, Eid BG, Mohamed SGA, Mohamed GA. | J Fungi (Basel) | 10.3390/jof7110943 | 2021 | |
| Comparative Evaluation of the Antibacterial and Antitumor Activities of 9-Phenylfascaplysin and Its Analogs. | Zhidkov ME, Sidorova MA, Smirnova PA, Tryapkin OA, Kachanov AV, Kantemirov AV, Dezhenkova LG, Grammatikova NE, Isakova EB, Shchekotikhin AE, Pak MA, Styshova ON, Klimovich AA, Popov AM. | Mar Drugs | 10.3390/md22020053 | 2024 | ||
| Naturally occurring prenylated flavonoids from African Erythrina plant species. | Tsakem B, Ntie Kang F, Teponno RB, Siwe Noundou X. | RSC Adv | 10.1039/d5ra03457d | 2025 | ||
| Enzymology | Sarothrin from Alkanna orientalis is an antimicrobial agent and efflux pump inhibitor. | Bame JR, Graf TN, Junio HA, Bussey RO, Jarmusch SA, El-Elimat T, Falkinham JO, Oberlies NH, Cech RA, Cech NB. | Planta Med | 10.1055/s-0032-1328259 | 2013 | |
| Pathogenicity | CRISPRi-mediated characterization of novel anti-tuberculosis targets: Mycobacterial peptidoglycan modifications promote beta-lactam resistance and intracellular survival. | Silveiro C, Marques M, Olivenca F, Pires D, Mortinho D, Nunes A, Pimentel M, Anes E, Catalao MJ. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1089911 | 2023 | |
| Enzymology | Crystal structure of decaprenylphosphoryl-beta- D-ribose 2'-epimerase from Mycobacterium smegmatis. | Li H, Jogl G. | Proteins | 10.1002/prot.24220 | 2013 | |
| Pathogenicity | Roles of Alanine Dehydrogenase and Induction of Its Gene in Mycobacterium smegmatis under Respiration-Inhibitory Conditions. | Jeong JA, Park SW, Yoon D, Kim S, Kang HY, Oh JI. | J Bacteriol | 10.1128/jb.00152-18 | 2018 | |
| Biological and Medicinal Properties of Natural Chromones and Chromanones. | Gaspar A, Garrido EMPJ, Borges F, Garrido JMPJ. | ACS Omega | 10.1021/acsomega.4c00771 | 2024 | ||
| Trichoderma-Derived Pentapeptides from the Infected Nest Mycobiome of the Subterranean Termite Coptotermes testaceus. | Oberpaul M, Brinkmann S, Spohn MS, Mihajlovic S, Marner M, Patras MA, Toti L, Kurz M, Hammann PE, Vilcinskas A, Glaeser J, Schaberle TF. | Chembiochem | 10.1002/cbic.202100698 | 2022 | ||
| Pathogenicity | Synthesis and Antibacterial Activity of Difluoromethyl Cinnamoyl Amides. | Martinez MD, Riva DA, Garcia C, Duran FJ, Burton G. | Molecules | 10.3390/molecules25040789 | 2020 | |
| Metabolism | Characterization of Mycobacterium smegmatis sigF mutant and its regulon: overexpression of SigF antagonist (MSMEG_1803) in M. smegmatis mimics sigF mutant phenotype, loss of pigmentation, and sensitivity to oxidative stress. | Singh AK, Dutta D, Singh V, Srivastava V, Biswas RK, Singh BN. | Microbiologyopen | 10.1002/mbo3.288 | 2015 | |
| Recent Advances in Anti-Tuberculosis Drug Discovery Based on Hydrazide-Hydrazone and Thiadiazole Derivatives Targeting InhA. | Teneva Y, Simeonova R, Valcheva V, Angelova VT. | Pharmaceuticals (Basel) | 10.3390/ph16040484 | 2023 | ||
| Genetics | Genomic and Chemical Decryption of the Bacteroidetes Phylum for Its Potential to Biosynthesize Natural Products. | Brinkmann S, Kurz M, Patras MA, Hartwig C, Marner M, Leis B, Billion A, Kleiner Y, Bauer A, Toti L, Poverlein C, Hammann PE, Vilcinskas A, Glaeser J, Spohn M, Schaberle TF. | Microbiol Spectr | 10.1128/spectrum.02479-21 | 2022 | |
| Identification of nontuberculous mycobacteria species by multiplex real-time PCR with high-resolution melting. | Peixoto ADS, Montenegro LML, Lima AS, Melo FL, Barbosa Junior WL, Neves MMC, Ramos JP, Schindler HC, Medeiros ZM. | Rev Soc Bras Med Trop | 10.1590/0037-8682-0211-2020 | 2020 | ||
| New Chromones from a Marine-Derived Fungus, Arthrinium sp., and Their Biological Activity. | Bao J, He F, Yu JH, Zhai H, Cheng ZQ, Jiang CS, Zhang Y, Zhang Y, Zhang X, Chen G, Zhang H. | Molecules | 10.3390/molecules23081982 | 2018 | ||
| Chaperone assisted recombinant expression of a mycobacterial aminoacylase in Vibrio natriegens and Escherichia coli capable of N-lauroyl-L-amino acid synthesis. | Haeger G, Wirges J, Tanzmann N, Oyen S, Jolmes T, Jaeger KE, Schorken U, Bongaerts J, Siegert P. | Microb Cell Fact | 10.1186/s12934-023-02079-1 | 2023 | ||
| Production of recombinant proteins in Mycobacterium smegmatis for structural and functional studies. | Bashiri G, Baker EN. | Protein Sci | 10.1002/pro.2584 | 2015 | ||
| Metabolism | Cryptic Sulfur Incorporation in Thioangucycline Biosynthesis. | Cao M, Zheng C, Yang D, Kalkreuter E, Adhikari A, Liu YC, Rateb ME, Shen B. | Angew Chem Int Ed Engl | 10.1002/anie.202015570 | 2021 | |
| Glucosamine/L-lactide copolymers as potential carriers for the development of a sustained rifampicin release system using Mycobacterium smegmatis as a tuberculosis model. | Ragusa J, Gonzalez D, Li S, Noriega S, Skotak M, Larsen G. | Heliyon | 10.1016/j.heliyon.2019.e01539 | 2019 | ||
| Glycopeptidolipid of Mycobacterium smegmatis J15cs Affects Morphology and Survival in Host Cells. | Fujiwara N, Ohara N, Ogawa M, Maeda S, Naka T, Taniguchi H, Yamamoto S, Ayata M. | PLoS One | 10.1371/journal.pone.0126813 | 2015 | ||
| Metabolism | SigF controls carotenoid pigment production and affects transformation efficiency and hydrogen peroxide sensitivity in Mycobacterium smegmatis. | Provvedi R, Kocincova D, Dona V, Euphrasie D, Daffe M, Etienne G, Manganelli R, Reyrat JM. | J Bacteriol | 10.1128/jb.00714-08 | 2008 | |
| Metabolism | The Ms6 Mycolyl-Arabinogalactan Esterase LysB is Essential for an Efficient Mycobacteriophage-Induced Lysis. | Gigante AM, Hampton CM, Dillard RS, Gil F, Catalao MJ, Moniz-Pereira J, Wright ER, Pimentel M. | Viruses | 10.3390/v9110343 | 2017 | |
| Enzymology | Genetic Mimetics of Mycobacterium tuberculosis and Methicillin-Resistant Staphylococcus aureus as Verification Standards for Molecular Diagnostics. | Machowski EE, Kana BD. | J Clin Microbiol | 10.1128/jcm.01111-17 | 2017 | |
| Antibiotic-Producing Beneficial Bacteria in the Gut of the Burying Beetle Nicrophorus vespilloides. | Heise P, Liu Y, Degenkolb T, Vogel H, Schaberle TF, Vilcinskas A. | Front Microbiol | 10.3389/fmicb.2019.01178 | 2019 | ||
| Novel Halogenated Pyrazine-Based Chalcones as Potential Antimicrobial Drugs. | Kucerova-Chlupacova M, Vyskovska-Tyllova V, Richterova-Finkova L, Kunes J, Buchta V, Vejsova M, Paterova P, Semelkova L, Jandourek O, Opletalova V. | Molecules | 10.3390/molecules21111421 | 2016 | ||
| Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria. | Hirsch R, Wiesner J, Bauer A, Marker A, Vogel H, Hammann PE, Vilcinskas A. | Microorganisms | 10.3390/microorganisms8050626 | 2020 | ||
| Development of a novel polymerase spiral reaction (PSR) assay for rapid and visual detection of Clostridium perfringens in meat. | Milton AAP, Momin KM, Ghatak S, Priya GB, Angappan M, Das S, Puro K, Sanjukta RK, Shakuntala I, Sen A, Kandpal BK. | Heliyon | 10.1016/j.heliyon.2021.e05941 | 2021 | ||
| Qualitative and quantitative proteomic analysis of Vitamin C induced changes in Mycobacterium smegmatis. | Mishra A, Sarkar D. | Front Microbiol | 10.3389/fmicb.2015.00451 | 2015 | ||
| Antibacterial and Antifungal Alkaloids from Asian Angiosperms: Distribution, Mechanisms of Action, Structure-Activity, and Clinical Potentials. | Sulaiman M, Jannat K, Nissapatorn V, Rahmatullah M, Paul AK, de Lourdes Pereira M, Rajagopal M, Suleiman M, Butler MS, Break MKB, Weber JF, Wilairatana P, Wiart C. | Antibiotics (Basel) | 10.3390/antibiotics11091146 | 2022 | ||
| Natural Polyether Ionophores and Their Pharmacological Profile. | Dembitsky VM. | Mar Drugs | 10.3390/md20050292 | 2022 | ||
| Metabolism | Novel Glycerophospholipid, Lipo- and N-acyl Amino Acids from Bacteroidetes: Isolation, Structure Elucidation and Bioactivity. | Bill MK, Brinkmann S, Oberpaul M, Patras MA, Leis B, Marner M, Maitre MP, Hammann PE, Vilcinskas A, Schuler SMM, Schaberle TF. | Molecules | 10.3390/molecules26175195 | 2021 | |
| The synthesis, biological evaluation and structure-activity relationship of 2-phenylaminomethylene-cyclohexane-1,3-diones as specific anti-tuberculosis agents. | Rather MA, Lone AM, Teli B, Bhat ZS, Singh P, Maqbool M, Shairgojray BA, Dar MJ, Amin S, Yousuf SK, Bhat BA, Ahmad Z, Ahmad Z. | Medchemcomm | 10.1039/c7md00350a | 2017 | ||
| Total synthesis and biological evaluation of transvalencin Z. | Nelson KM, Salomon CE, Aldrich CC. | J Nat Prod | 10.1021/np200972s | 2012 | ||
| Autofluorescence as a tool for structural analysis of biofilms formed by nonpigmented rapidly growing mycobacteria. | Munoz-Egea MC, Garcia-Pedrazuela M, Mahillo I, Garcia MJ, Esteban J. | Appl Environ Microbiol | 10.1128/aem.03149-12 | 2013 | ||
| Fluoroquinolones' Biological Activities against Laboratory Microbes and Cancer Cell Lines. | Suaifan GARY, Mohammed AAM, Alkhawaja BA. | Molecules | 10.3390/molecules27051658 | 2022 | ||
| Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance. | Chawla M, Verma J, Gupta R, Das B. | Front Microbiol | 10.3389/fmicb.2022.887251 | 2022 | ||
| Pathogenicity | Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment. | Gomez JE, Kaufmann-Malaga BB, Wivagg CN, Kim PB, Silvis MR, Renedo N, Ioerger TR, Ahmad R, Livny J, Fishbein S, Sacchettini JC, Carr SA, Hung DT. | Elife | 10.7554/elife.20420 | 2017 | |
| Substrate Tolerance of Bacterial Glycosyltransferase MurG: Novel Fluorescence-Based Assays. | Mitachi K, Yun HG, Gillman CD, Skorupinska-Tudek K, Swiezewska E, Clemons WM, Kurosu M. | ACS Infect Dis | 10.1021/acsinfecdis.9b00242 | 2020 | ||
| Pathogenicity | Separation of Five Iridoid Glycosides from Lonicerae Japonicae Flos Using High-Speed Counter-Current Chromatography and Their Anti-Inflammatory and Antibacterial Activities. | Yang R, Fang L, Li J, Zhao Z, Zhang H, Zhang Y. | Molecules | 10.3390/molecules24010197 | 2019 | |
| N-Nonyloxypentyl-l-Deoxynojirimycin Inhibits Growth, Biofilm Formation and Virulence Factors Expression of Staphylococcus aureus. | De Gregorio E, Esposito A, Vollaro A, De Fenza M, D'Alonzo D, Migliaccio A, Iula VD, Zarrilli R, Guaragna A. | Antibiotics (Basel) | 10.3390/antibiotics9060362 | 2020 | ||
| Enzymology | Regulation of the ahpC gene encoding alkyl hydroperoxide reductase in Mycobacterium smegmatis. | Lee HN, Lee NO, Han SJ, Ko IJ, Oh JI. | PLoS One | 10.1371/journal.pone.0111680 | 2014 | |
| Antimicrobial Peptides: Novel Source and Biological Function With a Special Focus on Entomopathogenic Nematode/Bacterium Symbiotic Complex. | De Mandal S, Panda AK, Murugan C, Xu X, Senthil Kumar N, Jin F. | Front Microbiol | 10.3389/fmicb.2021.555022 | 2021 | ||
| Antimicrobial and antiurease activities of newly synthesized morpholine derivatives containing an azole nucleus. | Bektas H, Ceylan S, Demirbas N, Alpay-Karaoglu S, Sokmen BB. | Med Chem Res | 10.1007/s00044-012-0318-1 | 2013 | ||
| Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation. | Jandourek O, Tauchman M, Paterova P, Konecna K, Navratilova L, Kubicek V, Holas O, Zitko J, Dolezal M. | Molecules | 10.3390/molecules22020223 | 2017 | ||
| Pathogenicity | In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria. | Fernandez-Roblas R, Martin-de-Hijas NZ, Fernandez-Martinez AI, Garcia-Almeida D, Gadea I, Esteban J. | Antimicrob Agents Chemother | 10.1128/aac.00695-08 | 2008 | |
| Pathogenicity | Prevention of drug carryover effects in studies assessing antimycobacterial efficacy of TMC207. | Lounis N, Gevers T, Van Den Berg J, Verhaeghe T, van Heeswijk R, Andries K. | J Clin Microbiol | 10.1128/jcm.00177-08 | 2008 | |
| Use of mycobacteriophage quantitative PCR on MGIT broths for a rapid tuberculosis antibiogram. | Foongladda S, Klayut W, Chinli R, Pholwat S, Houpt ER. | J Clin Microbiol | 10.1128/jcm.03637-13 | 2014 | ||
| Phytochemical, Cytotoxicity, and Antimycobacterial Activity Evaluation of Extracts and Compounds from the Stem Bark of Albizia coriaria Welw ex. Oliver. | Obakiro SB, Kiprop A, K'owino I, Andima M, Owor RO, Chacha R, Kigondu E. | Evid Based Complement Alternat Med | 10.1155/2022/7148511 | 2022 | ||
| Metabolism | Regulation of the ald gene encoding alanine dehydrogenase by AldR in Mycobacterium smegmatis. | Jeong JA, Baek EY, Kim SW, Choi JS, Oh JI. | J Bacteriol | 10.1128/jb.00482-13 | 2013 | |
| Metabolism | Identification of the polyketide synthase involved in the biosynthesis of the surface-exposed lipooligosaccharides in mycobacteria. | Etienne G, Malaga W, Laval F, Lemassu A, Guilhot C, Daffe M. | J Bacteriol | 10.1128/jb.01235-08 | 2009 | |
| Metabolism | The SigF regulon in Mycobacterium smegmatis reveals roles in adaptation to stationary phase, heat, and oxidative stress. | Humpel A, Gebhard S, Cook GM, Berney M. | J Bacteriol | 10.1128/jb.00035-10 | 2010 | |
| Pathogenicity | Effect of ciprofloxacin in the ultrastructure and development of biofilms formed by rapidly growing mycobacteria. | Munoz-Egea MC, Garcia-Pedrazuela M, Mahillo I, Esteban J. | BMC Microbiol | 10.1186/s12866-015-0359-y | 2015 | |
| Biofilm development by potentially pathogenic non-pigmented rapidly growing mycobacteria. | Esteban J, Martin-de-Hijas NZ, Kinnari TJ, Ayala G, Fernandez-Roblas R, Gadea I. | BMC Microbiol | 10.1186/1471-2180-8-184 | 2008 | ||
| Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env. | Cayabyab MJ, Hovav AH, Hsu T, Krivulka GR, Lifton MA, Gorgone DA, Fennelly GJ, Haynes BF, Jacobs WR, Letvin NL. | J Virol | 10.1128/jvi.80.4.1645-1652.2006 | 2006 | ||
| Enzymology | Angucyclines and Angucyclinones from Streptomyces sp. CB01913 Featuring C-Ring Cleavage and Expansion. | Ma M, Rateb ME, Teng Q, Yang D, Rudolf JD, Zhu X, Huang Y, Zhao LX, Jiang Y, Li X, Rader C, Duan Y, Shen B. | J Nat Prod | 10.1021/acs.jnatprod.5b00601 | 2015 | |
| The secondary metabolites of rare actinomycetes: chemistry and bioactivity. | Ding T, Yang LJ, Zhang WD, Shen YH. | RSC Adv | 10.1039/c9ra03579f | 2019 | ||
| Teixobactin analogues reveal enduracididine to be non-essential for highly potent antibacterial activity and lipid II binding. | Parmar A, Iyer A, Prior SH, Lloyd DG, Leng Goh ET, Vincent CS, Palmai-Pallag T, Bachrati CZ, Breukink E, Madder A, Lakshminarayanan R, Taylor EJ, Singh I. | Chem Sci | 10.1039/c7sc03241b | 2017 | ||
| Recent insights on nanomedicine for augmented infection control. | Singh S, Hussain A, Shakeel F, Ahsan MJ, Alshehri S, Webster TJ, Lal UR. | Int J Nanomedicine | 10.2147/ijn.s170280 | 2019 | ||
| Enzymology | Crystallization and preliminary X-ray analysis of the ergothioneine-biosynthetic methyltransferase EgtD. | Vit A, Misson L, Blankenfeldt W, Seebeck FP. | Acta Crystallogr F Struct Biol Commun | 10.1107/s2053230x1400805x | 2014 | |
| Single-Fluorescence ATP Sensor Based on Fluorescence Resonance Energy Transfer Reveals Role of Antibiotic-Induced ATP Perturbation in Mycobacterial Killing. | Liang L, Lin D, Chen Y, Li J, Liang W, Zhao H, Luo W, Tian GB, Feng S. | mSystems | 10.1128/msystems.00209-22 | 2022 | ||
| Novel FR-900493 Analogues That Inhibit the Outgrowth of Clostridium difficile Spores. | Mitachi K, Yun HG, Kurosu SM, Eslamimehr S, Lemieux MR, Klaic L, Clemons WM, Kurosu M. | ACS Omega | 10.1021/acsomega.7b01740 | 2018 | ||
| Metabolism | O2- and NO-sensing mechanism through the DevSR two-component system in Mycobacterium smegmatis. | Lee JM, Cho HY, Cho HJ, Ko IJ, Park SW, Baik HS, Oh JH, Eom CY, Kim YM, Kang BS, Oh JI. | J Bacteriol | 10.1128/jb.00401-08 | 2008 | |
| Metabolism | Different roles of DosS and DosT in the hypoxic adaptation of Mycobacteria. | Kim MJ, Park KJ, Ko IJ, Kim YM, Oh JI. | J Bacteriol | 10.1128/jb.00550-10 | 2010 | |
| Enzymology | Biological Activities of Some New Secondary Metabolites Isolated from Endophytic Fungi: A Review Study. | Zheng R, Li S, Zhang X, Zhao C. | Int J Mol Sci | 10.3390/ijms22020959 | 2021 | |
| Enzymology | 3-Substituted N-Benzylpyrazine-2-carboxamide Derivatives: Synthesis, Antimycobacterial and Antibacterial Evaluation. | Semelkova L, Jandourek O, Konecna K, Paterova P, Navratilova L, Trejtnar F, Kubicek V, Kunes J, Dolezal M, Zitko J. | Molecules | 10.3390/molecules22030495 | 2017 | |
| Biosynthesis of Galactan in Mycobacterium tuberculosis as a Viable TB Drug Target? | Konyarikova Z, Savkova K, Kozmon S, Mikusova K. | Antibiotics (Basel) | 10.3390/antibiotics9010020 | 2020 | ||
| Enduracididine, a rare amino acid component of peptide antibiotics: Natural products and synthesis. | Atkinson DJ, Naysmith BJ, Furkert DP, Brimble MA. | Beilstein J Org Chem | 10.3762/bjoc.12.226 | 2016 | ||
| Phylogeny | Linear Triquinane Sesquiterpenoids: Their Isolation, Structures, Biological Activities, and Chemical Synthesis. | Qiu Y, Lan WJ, Li HJ, Chen LP. | Molecules | 10.3390/molecules23092095 | 2018 | |
| A second endolysin gene is fully embedded in-frame with the lysA gene of mycobacteriophage Ms6. | Catalao MJ, Milho C, Milho C, Gil F, Moniz-Pereira J, Pimentel M. | PLoS One | 10.1371/journal.pone.0020515 | 2011 | ||
| Pathogenicity | Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors. | Siricilla S, Mitachi K, Wan B, Franzblau SG, Kurosu M. | J Antibiot (Tokyo) | 10.1038/ja.2014.133 | 2015 | |
| Metabolism | Cholesterol utilization in mycobacteria is controlled by two TetR-type transcriptional regulators: kstR and kstR2. | Kendall SL, Burgess P, Balhana R, Withers M, Ten Bokum A, Lott JS, Gao C, Uhia-Castro I, Stoker NG. | Microbiology (Reading) | 10.1099/mic.0.034538-0 | 2010 | |
| Metabolism | Effect of exogenous fatty acids on ethambutol susceptibility of sensitive and resistant Mycobacterium smegmatis ATCC 607. | Cheema S, Asotra S, Khuller GK. | Indian J Exp Biol | 1987 | ||
| Enzymology | A glycosyltransferase involved in biosynthesis of triglycosylated glycopeptidolipids in Mycobacterium smegmatis: impact on surface properties. | Deshayes C, Laval F, Montrozier H, Daffe M, Etienne G, Reyrat JM. | J Bacteriol | 10.1128/jb.187.21.7283-7291.2005 | 2005 | |
| Metabolism | Metabolism of phospholipids in Mycobacterium smegmatis ATCC 607 in the presence of ethambutol. | Cheema S, Khuller GK. | Indian J Med Res | 1985 | ||
| Phospholipid composition and ethambutol sensitivity of Mycobacterium smegmatis ATCC 607. | Cheema S, Khuller GK. | Indian J Exp Biol | 1985 | |||
| Metabolism | Effect of altered lipid composition on amino acid uptake in Mycobacterium smegmatis ATCC 607. | Mahajan S, Khuller GK. | Indian J Biochem Biophys | 1985 | ||
| Enzymology | Purification, gene cloning, targeted knockout, overexpression, and biochemical characterization of the major pyrazinamidase from Mycobacterium smegmatis. | Boshoff HI, Mizrahi V. | J Bacteriol | 10.1128/jb.180.22.5809-5814.1998 | 1998 | |
| A review of medicinal plant of Middle East and North Africa (MENA) region as source in tuberculosis drug discovery. | Dehyab AS, Bakar MFA, AlOmar MK, Sabran SF. | Saudi J Biol Sci | 10.1016/j.sjbs.2020.07.007 | 2020 | ||
| Pathogenicity | An antimycobacterial pleuromutilin analogue effective against dormant bacilli. | Lemieux MR, Siricilla S, Mitachi K, Eslamimehr S, Wang Y, Yang D, Pressly JD, Kong Y, Park F, Franzblau SG, Kurosu M. | Bioorg Med Chem | 10.1016/j.bmc.2018.07.034 | 2018 | |
| Rapid construction of mycobacterial mutagenesis vectors using ligation-independent cloning. | Balhana R, Stoker NG, Sikder MH, Chauviac FX, Kendall SL. | J Microbiol Methods | 10.1016/j.mimet.2010.07.014 | 2010 | ||
| Design, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with a 4-phenylthiazol-2-amine scaffold. | Zitko J, Jand'ourek O, Paterova P, Navratilova L, Kunes J, Vinsova J, Dolezal M. | Medchemcomm | 10.1039/c8md00056e | 2018 | ||
| Metabolism | Characterization of the cydAB-encoded cytochrome bd oxidase from Mycobacterium smegmatis. | Kana BD, Weinstein EA, Avarbock D, Dawes SS, Rubin H, Mizrahi V. | J Bacteriol | 10.1128/jb.183.24.7076-7086.2001 | 2001 | |
| Pathogenicity | Effects of ethanol on phospholipid composition and metabolism of Mycobacterium smegmatis ATCC 607. | Taneja R, Khuller GK. | Indian J Med Res | 1982 | ||
| Metabolism | Screening system for xenosiderophores as potential drug delivery agents in mycobacteria. | Schumann G, Mollmann U. | Antimicrob Agents Chemother | 10.1128/aac.45.5.1317-1322.2001 | 2001 | |
| Galleria mellonella-intracellular bacteria pathogen infection models: the ins and outs. | Asai M, Li Y, Newton SM, Robertson BD, Langford PR. | FEMS Microbiol Rev | 10.1093/femsre/fuad011 | 2023 | ||
| Lack of fusion of azurophil granules with phagosomes during phagocytosis of Mycobacterium smegmatis by human neutrophils is not actively controlled by the bacterium. | Cougoule C, Constant P, Etienne G, Daffe M, Maridonneau-Parini I. | Infect Immun | 10.1128/iai.70.3.1591-1598.2002 | 2002 | ||
| The oxazolomycin family: a review of current knowledge. | Oleksak P, Gonda J, Nepovimova E, Kuca K, Musilek K. | RSC Adv | 10.1039/d0ra08396h | 2020 | ||
| Identification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistry. | Hong SY, Oh JE, Kwon M, Choi MJ, Lee JH, Lee BL, Moon HM, Lee KH. | Antimicrob Agents Chemother | 10.1128/aac.42.10.2534 | 1998 | ||
| Enzymology | Bacilysocin, a novel phospholipid antibiotic produced by Bacillus subtilis 168. | Tamehiro N, Okamoto-Hosoya Y, Okamoto S, Ubukata M, Hamada M, Naganawa H, Ochi K. | Antimicrob Agents Chemother | 10.1128/aac.46.2.315-320.2002 | 2002 | |
| Metabolism | A highly conserved transcriptional repressor controls a large regulon involved in lipid degradation in Mycobacterium smegmatis and Mycobacterium tuberculosis. | Kendall SL, Withers M, Soffair CN, Moreland NJ, Gurcha S, Sidders B, Frita R, Ten Bokum A, Besra GS, Lott JS, Stoker NG. | Mol Microbiol | 10.1111/j.1365-2958.2007.05827.x | 2007 | |
| Enzymology | Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides. | Boshoff HI, Mizrahi V. | J Bacteriol | 10.1128/jb.182.19.5479-5485.2000 | 2000 | |
| Metabolism | Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains. | Zhang T, Bishai WR, Grosset JH, Nuermberger EL. | Antimicrob Agents Chemother | 10.1128/aac.00400-10 | 2010 | |
| Pathogenicity | Antimycobacterial activities of antisense oligodeoxynucleotide phosphorothioates in drug-resistant strains. | Rapaport E, Levina A, Metelev V, Zamecnik PC. | Proc Natl Acad Sci U S A | 10.1073/pnas.93.2.709 | 1996 | |
| The alr-groEL1 operon in Mycobacterium tuberculosis: an interplay of multiple regulatory elements. | Bhat AH, Pathak D, Rao A. | Sci Rep | 10.1038/srep43772 | 2017 | ||
| Expression of Mycobacteriophage Ms6 lysis genes is driven by two sigma(70)-like promoters and is dependent on a transcription termination signal present in the leader RNA. | Garcia M, Pimentel M, Moniz-Pereira J. | J Bacteriol | 10.1128/jb.184.11.3034-3043.2002 | 2002 | ||
| Metabolism | Epoxyalkane: coenzyme M transferase in the ethene and vinyl chloride biodegradation pathways of mycobacterium strain JS60. | Coleman NV, Spain JC. | J Bacteriol | 10.1128/jb.185.18.5536-5545.2003 | 2003 | |
| Metabolism | Biochemical and genetic evidence for phospholipase C activity in Mycobacterium ulcerans. | Gomez A, Mve-Obiang A, Vray B, Remacle J, Chemlal K, Meyers WM, Portaels F, Fonteyne PA. | Infect Immun | 10.1128/iai.68.5.2995-2997.2000 | 2000 | |
| Metabolism | Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug. | Silve G, Valero-Guillen P, Quemard A, Dupont MA, Daffe M, Laneelle G. | Antimicrob Agents Chemother | 10.1128/aac.37.7.1536 | 1993 | |
| Metabolism | Sorbicillinoid analogs with cytotoxic and selective anti-Aspergillus activities from Scytalidium album. | El-Elimat T, Raja HA, Figueroa M, Swanson SM, Falkinham JO, Lucas DM, Grever MR, Wani MC, Pearce CJ, Oberlies NH. | J Antibiot (Tokyo) | 10.1038/ja.2014.125 | 2015 | |
| Function of the cytochrome bc1-aa3 branch of the respiratory network in mycobacteria and network adaptation occurring in response to its disruption. | Matsoso LG, Kana BD, Crellin PK, Lea-Smith DJ, Pelosi A, Powell D, Dawes SS, Rubin H, Coppel RL, Mizrahi V. | J Bacteriol | 10.1128/jb.187.18.6300-6308.2005 | 2005 | ||
| Metabolism | Mycobacterium smegmatis dnaA region and autonomous replication activity. | Rajagopalan M, Qin MH, Nash DR, Madiraju MV. | J Bacteriol | 10.1128/jb.177.22.6527-6535.1995 | 1995 | |
| PhoY2 but not PhoY1 is the PhoU homologue involved in persisters in Mycobacterium tuberculosis. | Shi W, Zhang Y. | J Antimicrob Chemother | 10.1093/jac/dkq103 | 2010 | ||
| Stingless Bee-Collected Pollen (Bee Bread): Chemical and Microbiology Properties and Health Benefits. | Mohammad SM, Mahmud-Ab-Rashid NK, Zawawi N. | Molecules | 10.3390/molecules26040957 | 2021 | ||
| Enzymology | High-performance liquid chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium smegmatis. | Butler WR, Kilburn JO. | J Clin Microbiol | 10.1128/jcm.28.9.2094-2098.1990 | 1990 | |
| The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages. | Roux AL, Viljoen A, Bah A, Simeone R, Bernut A, Laencina L, Deramaudt T, Rottman M, Gaillard JL, Majlessi L, Brosch R, Girard-Misguich F, Vergne I, de Chastellier C, Kremer L, Herrmann JL. | Open Biol | 10.1098/rsob.160185 | 2016 | ||
| Pathogenicity | Preliminary observations on the occurrence of a streptomycin R-factor in Mycobacterium smegmatis ATCC 607. | Jones WD, David HL. | Tubercle | 10.1016/0041-3879(72)90044-x | 1972 | |
| [Genetic map of Mycobacterium smegmatis ATCC 607]. | Mizuguchi Y. | Igaku To Seibutsugaku | 1970 | |||
| Enzymology | Fluorescence-based assay for polyprenyl phosphate-GlcNAc-1-phosphate transferase (WecA) and identification of novel antimycobacterial WecA inhibitors. | Mitachi K, Siricilla S, Yang D, Kong Y, Skorupinska-Tudek K, Swiezewska E, Franzblau SG, Kurosu M. | Anal Biochem | 10.1016/j.ab.2016.08.008 | 2016 | |
| Enzymology | Biosynthesis of a lipase by Mycobacterium smegmatis ATCC 607 infected by Mycobacteriophage D29. | David HL, Jones WD. | Am Rev Respir Dis | 10.1164/arrd.1970.102.5.818 | 1970 | |
| Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis. | Caceres NE, Harris NB, Wellehan JF, Feng Z, Kapur V, Barletta RG. | J Bacteriol | 10.1128/jb.179.16.5046-5055.1997 | 1997 | ||
| The occurrence of lipids in Mycobacteriophage D29 propagated in Mycobacterium smegmatis ATCC 607. | Jones WD, David HL, Beam RE. | Am Rev Respir Dis | 10.1164/arrd.1970.102.5.814 | 1970 | ||
| [Change in virulence of the saprophytic strain Mycobacterium smegmatitis ATCC 607 when mixed with Mycobacterium tuberculosis H37Rv in the mouse peritoneal cavity]. | Djurovic V. | Rev Tuberc Pneumol (Paris) | 1972 | |||
| Metabolism | Biosynthesis of a water-soluble lipid I analogue and a convenient assay for translocase I. | Siricilla S, Mitachi K, Skorupinska-Tudek K, Swiezewska E, Kurosu M. | Anal Biochem | 10.1016/j.ab.2014.05.018 | 2014 | |
| Pathogenicity | Real-time PCR using mycobacteriophage DNA for rapid phenotypic drug susceptibility results for Mycobacterium tuberculosis. | Pholwat S, Ehdaie B, Foongladda S, Kelly K, Houpt E. | J Clin Microbiol | 10.1128/jcm.01315-11 | 2012 | |
| Gene Expression, Bacteria Viability and Survivability Following Spray Drying of Mycobacterium smegmatis | Lauten E, Pulliam B, DeRousse J, Bhatta D, Edwards D. | Materials (Basel) | 2010 | |||
| Cytometric detection of mycobacterial surface antigens: exposure of mannosyl epitopes and of the arabinan segment of arabinomannans. | Ozanne V, Ortalo-Magne A, Vercellone A, Fournie JJ, Daffe M. | J Bacteriol | 10.1128/jb.178.24.7254-7259.1996 | 1996 | ||
| Genetics | Unusual large-scale chromosomal rearrangements in Mycobacterium tuberculosis Beijing B0/W148 cluster isolates. | Shitikov EA, Bespyatykh JA, Ischenko DS, Alexeev DG, Karpova IY, Kostryukova ES, Isaeva YD, Nosova EY, Mokrousov IV, Vyazovaya AA, Narvskaya OV, Vishnevsky BI, Otten TF, Zhuravlev VIu, Yablonsky PK, Ilina EN, Govorun VM. | PLoS One | 10.1371/journal.pone.0084971 | 2014 | |
| A novel transposon trap for mycobacteria: isolation and characterization of IS1096. | Cirillo JD, Barletta RG, Bloom BR, Jacobs WR. | J Bacteriol | 10.1128/jb.173.24.7772-7780.1991 | 1991 | ||
| Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. | Ortalo-Magne A, Lemassu A, Laneelle MA, Bardou F, Silve G, Gounon P, Marchal G, Daffe M. | J Bacteriol | 10.1128/jb.178.2.456-461.1996 | 1996 | ||
| Metabolism | Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis. | Kilburn JO, Takayama K. | Antimicrob Agents Chemother | 10.1128/aac.20.3.401 | 1981 | |
| Enzymology | DEOXYRIBONUCLEIC ACID, PROTEIN, AND INDUCIBLE ENZYME SYNTHESIS IN PHAGE-INFECTED MYCOBACTERIUM SMEGMATIS ATCC 607. | CARLBERG DM, JANN GJ. | Am Rev Respir Dis | 10.1164/arrd.1963.88.2.235 | 1963 | |
| Mycosides C: behavior as receptor site substance for mycobacteriophage D4. | Goren MB, McClatchy JK, Martens B, Brokl O. | J Virol | 10.1128/jvi.9.6.999-1003.1972 | 1972 | ||
| Enzymology | Inhibition of the first step in synthesis of the mycobacterial cell wall core, catalyzed by the GlcNAc-1-phosphate transferase WecA, by the novel caprazamycin derivative CPZEN-45. | Ishizaki Y, Hayashi C, Inoue K, Igarashi M, Takahashi Y, Pujari V, Crick DC, Brennan PJ, Nomoto A. | J Biol Chem | 10.1074/jbc.m113.492173 | 2013 | |
| Metabolism | Chlorinated fatty acid distribution in Mycobacterium convolutum phospholipids after growth on 1-chlorohexadecane. | Murphy GL, Perry JJ. | Appl Environ Microbiol | 10.1128/aem.53.1.10-13.1987 | 1987 | |
| Metabolism | Ethambutol-mediated alterations in ribonucleic acid components of Mycobacterium smegmatis. | Bacalao J, Rieber M. | J Bacteriol | 10.1128/jb.112.2.1004-1006.1972 | 1972 | |
| Biological evaluation of plants of Laos used in the treatment of tuberculosis in Lao traditional medicine. | Elkington BG, Southavong B, Sydara K, Souliya O, Vanthanouvong M, Nettavong K, Thammachack B, Pak DH, Riley MC, Franzblau SG, Soejarto DD. | Pharm Biol | 10.1080/13880200802398002 | 2009 | ||
| Protoplast formation of selected Mycobacterium smegmatis mutants by lysozyme in combination with methionine. | Yabu K, Takahashi S. | J Bacteriol | 10.1128/jb.129.3.1628-1631.1977 | 1977 | ||
| Pathogenicity | Transduction of isoniazid susceptibility-resistance and streptomycin resistance in mycobacteria. | Saroja D, Gopinathan KP. | Antimicrob Agents Chemother | 10.1128/aac.4.6.643 | 1973 | |
| Physiological factors involved in the transformation of Mycobacterium smegmatis. | Norgard MV, Imaeda T. | J Bacteriol | 10.1128/jb.133.3.1254-1262.1978 | 1978 | ||
| Pathogenicity | A Novel Small-Molecule Inhibitor of the Mycobacterium tuberculosis Demethylmenaquinone Methyltransferase MenG Is Bactericidal to Both Growing and Nutritionally Deprived Persister Cells. | Sukheja P, Kumar P, Mittal N, Li SG, Singleton E, Russo R, Perryman AL, Shrestha R, Awasthi D, Husain S, Soteropoulos P, Brukh R, Connell N, Freundlich JS, Alland D. | mBio | 10.1128/mbio.02022-16 | 2017 | |
| Metabolism | Haptenic oligosaccharides in antigenic variants of mycobacterial C-mycosides antagonize lipid receptor activity for mycobacteriophage D4 by masking a methylated rhamnose. | Dhariwal KR, Liav A, Vatter AE, Dhariwal G, Goren MB. | J Bacteriol | 10.1128/jb.168.1.283-293.1986 | 1986 | |
| Cloning, sequencing, and expression of the mig gene of Mycobacterium avium, which codes for a secreted macrophage-induced protein. | Plum G, Brenden M, Clark-Curtiss JE, Pulverer G. | Infect Immun | 10.1128/iai.65.11.4548-4557.1997 | 1997 | ||
| Metabolism | Identification of the apparent carrier in mycolic acid synthesis. | Besra GS, Sievert T, Lee RE, Slayden RA, Brennan PJ, Takayama K. | Proc Natl Acad Sci U S A | 10.1073/pnas.91.26.12735 | 1994 | |
| Phylogeny | Duplication of the tuf gene: a new insight into the phylogeny of eubacteria. | Sela S, Yogev D, Razin S, Bercovier H. | J Bacteriol | 10.1128/jb.171.1.581-584.1989 | 1989 | |
| Metabolism | Nonopsonic phagocytosis of zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation. | Le Cabec V, Cols C, Maridonneau-Parini I. | Infect Immun | 10.1128/iai.68.8.4736-4745.2000 | 2000 | |
| Enzymology | Isolation of plasmids from mycobacteria. | Crawford JT, Bates JH. | Infect Immun | 10.1128/iai.24.3.979-981.1979 | 1979 | |
| Enzymology | Identification of major slowly growing pathogenic mycobacteria and Mycobacterium gordonae by high-performance liquid chromatography of their mycolic acids. | Butler WR, Kilburn JO. | J Clin Microbiol | 10.1128/jcm.26.1.50-53.1988 | 1988 | |
| Lysogeny and transformation in mycobacteria: stable expression of foreign genes. | Snapper SB, Lugosi L, Jekkel A, Melton RE, Kieser T, Bloom BR, Jacobs WR. | Proc Natl Acad Sci U S A | 10.1073/pnas.85.18.6987 | 1988 | ||
| Structure of native and chloroform-methanol-treated mycobacteriophage R1. | Fay D, Bowman BU. | J Virol | 10.1128/jvi.27.2.432-435.1978 | 1978 | ||
| Metabolism | Characterization of autolysins from Mycobacterium smegmatis. | Kilburn JO, Best GK. | J Bacteriol | 10.1128/jb.129.2.750-755.1977 | 1977 | |
| Massive gene duplication event among clinical isolates of the Mycobacterium tuberculosis W/Beijing family. | Domenech P, Kolly GS, Leon-Solis L, Fallow A, Reed MB. | J Bacteriol | 10.1128/jb.00536-10 | 2010 | ||
| Enzymology | Functional analysis of the holin-like proteins of mycobacteriophage Ms6. | Catalao MJ, Gil F, Moniz-Pereira J, Pimentel M. | J Bacteriol | 10.1128/jb.01519-10 | 2011 | |
| Phylogeny | Discriminatory power and reproducibility of novel DNA typing methods for Mycobacterium tuberculosis complex strains. | Kremer K, Arnold C, Cataldi A, Gutierrez MC, Haas WH, Panaiotov S, Skuce RA, Supply P, van der Zanden AG, van Soolingen D. | J Clin Microbiol | 10.1128/jcm.43.11.5628-5638.2005 | 2005 | |
| Gene replacement and expression of foreign DNA in mycobacteria. | Husson RN, James BE, Young RA. | J Bacteriol | 10.1128/jb.172.2.519-524.1990 | 1990 | ||
| Phylogeny | Use of randomly amplified polymorphic DNA as a means of developing genus- and strain-specific Streptomyces DNA probes. | Roberts MA, Crawford DL. | Appl Environ Microbiol | 10.1128/aem.66.6.2555-2564.2000 | 2000 | |
| Enzymology | Method for isolation of deoxyribonucleic acid from mycobacteria. | Mizuguchi Y, Tokunaga T. | J Bacteriol | 10.1128/jb.104.2.1020-1021.1970 | 1970 | |
| Phylogeny | High-performance liquid chromatography of mycolic acids as a tool in the identification of Corynebacterium, Nocardia, Rhodococcus, and Mycobacterium species. | Butler WR, Ahearn DG, Kilburn JO. | J Clin Microbiol | 10.1128/jcm.23.1.182-185.1986 | 1986 | |
| Metabolism | EFFECT OF ETHAMBUTOL ON NUCLEIC ACID METABOLISM IN MYCOBACTERIUM SMEGMATIS AND ITS REVERSAL BY POLYAMINES AND DIVALENT CATIONS. | FORBES M, KUCK NA, PEETS EA. | J Bacteriol | 10.1128/jb.89.5.1299-1305.1965 | 1965 | |
| Infection of Mycobacterium tuberculosis with deoxyribonucleic acid extracted from mycobacteriophage B1. | Tokunaga T, Nakamura RM. | J Virol | 10.1128/jvi.1.2.448-449.1967 | 1967 | ||
| Enzymology | Use of a phage-based assay for phenotypic detection of mycobacteria directly from sputum. | Park DJ, Drobniewski FA, Meyer A, Wilson SM. | J Clin Microbiol | 10.1128/jcm.41.2.680-688.2003 | 2003 | |
| Relationship between the structures of fatty acid amide derivatives and their antimicrobial activities. | Omura S, Katagiri M, Awaya J, Furukawa T, Umezawa I, Oi N, Mizoguchi M, Aoki B, Shindo M. | Antimicrob Agents Chemother | 10.1128/aac.6.2.207 | 1974 | ||
| Phylogeny | Interrelationships among Mycobacteria and Nocardiae. | Manion RE, Bradley SG, Zinneman HH, Hall WH. | J Bacteriol | 10.1128/jb.87.5.1056-1059.1964 | 1964 | |
| Alteration of colony morphology of mycobacteria associated with lysogeny. | WHITE A, FOSTER F, LYON L. | J Bacteriol | 10.1128/jb.84.4.815-818.1962 | 1962 | ||
| Rapidly growing, acid fast bacteria. I. Species' descriptions of Mycobacterium phlei Lehmann and Neumann and Mycobacterium smegmatis (Trevisan) Lehmann and Neumann. | GORDON RE, SMITH MM. | J Bacteriol | 10.1128/jb.66.1.41-48.1953 | 1953 | ||
| INFECTION OF MYCOBACTERIUM SMEGMATIS WITH D29 PHAGE DNA. | TOKUNAGA T, SELLERS M. | J Exp Med | 10.1084/jem.119.1.139 | 1964 | ||
| Pathogenicity | Inhibition of growth of Mycobacterium smegmatis and of cell wall synthesis by D-serine. | Yabu K, Huempfner HR. | Antimicrob Agents Chemother | 10.1128/aac.6.1.1 | 1974 | |
| Thermal Tolerance of Zymomonas mobilis: Temperature-Induced Changes in Membrane Composition. | Benschoter AS, Ingram LO. | Appl Environ Microbiol | 10.1128/aem.51.6.1278-1284.1986 | 1986 | ||
| Mechanism of Action of Ribosomally Synthesized and Post-Translationally Modified Peptides. | Ongpipattanakul C, Desormeaux EK, DiCaprio A, van der Donk WA, Mitchell DA, Nair SK. | Chem Rev | 10.1021/acs.chemrev.2c00210 | 2022 | ||
| Metabolism | Amino acid transport in Mycobacterium smegmatis. | Yabu K. | J Bacteriol | 10.1128/jb.102.1.6-13.1970 | 1970 | |
| Infection of competent Mycobacterium smegmatis with deoxyribonucleic acid extracted from bacteriophage B1. | Tokunaga T, Nakamura RM. | J Virol | 10.1128/jvi.2.2.110-117.1968 | 1968 | ||
| Studies on autolysis of mycobacteria. II. Autolysis of various pathogenic and nonpathogenic strains grown in a medium deficient in nitrogen. | REDMOND WB. | J Bacteriol | 10.1128/jb.73.2.279-283.1957 | 1957 | ||
| New Selective Growth Inhibitors of Sphaerotilus natans, Anslimins A and B. | Takiguchi Y, Yoshikawa H, Terao M. | Appl Environ Microbiol | 10.1128/aem.39.6.1123-1128.1980 | 1980 | ||
| Characterization and taxonomic implications of the rRNA genes of Mycobacterium leprae. | Sela S, Clark-Curtiss JE, Bercovier H. | J Bacteriol | 10.1128/jb.171.1.70-73.1989 | 1989 | ||
| Isolation and characterization of a native composite transposon, Tn14751, carrying 17.4 kilobases of Corynebacterium glutamicum chromosomal DNA. | Inui M, Tsuge Y, Suzuki N, Vertes AA, Yukawa H. | Appl Environ Microbiol | 10.1128/aem.71.1.407-416.2005 | 2005 | ||
| Enzymology | Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst. | Piddington DL, Fang FC, Laessig T, Cooper AM, Orme IM, Buchmeier NA. | Infect Immun | 10.1128/iai.69.8.4980-4987.2001 | 2001 | |
| Isolation and characterization of antibiotic LL-AC541. | Zbinovsky V, Hausmann WK, Wetzel ER, Borders DB, Patterson EL. | Appl Microbiol | 10.1128/am.16.4.614-616.1968 | 1968 | ||
| Genetics | Nitrosoguanidine sequential mutagenesis mapping of Mycobacterium tuberculosis genes. | Woodley CL, Baldwin JN, Greenberg J. | J Bacteriol | 10.1128/jb.147.1.176-180.1981 | 1981 | |
| Metabolism | Biosynthetic origin of mycobacterial cell wall arabinosyl residues. | Scherman M, Weston A, Duncan K, Whittington A, Upton R, Deng L, Comber R, Friedrich JD, McNeil M. | J Bacteriol | 10.1128/jb.177.24.7125-7130.1995 | 1995 | |
| Metabolism | Production of new hybrid antibiotics, mederrhodins A and B, by a genetically engineered strain. | Omura S, Ikeda H, Malpartida F, Kieser HM, Hopwood DA. | Antimicrob Agents Chemother | 10.1128/aac.29.1.13 | 1986 | |
| Enzymology | Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. | Kremer K, van Soolingen D, Frothingham R, Haas WH, Hermans PW, Martin C, Palittapongarnpim P, Plikaytis BB, Riley LW, Yakrus MA, Musser JM, van Embden JD. | J Clin Microbiol | 10.1128/jcm.37.8.2607-2618.1999 | 1999 | |
| Further studies of infectious DNA extracted from mycobacteriophages. | Sellers MI, Tokunaga T. | J Exp Med | 10.1084/jem.123.2.327 | 1966 | ||
| Phylogeny | Motile nocardoid Actinomycetales. | Sukapure RS, Lechevalier MP, Reber H, Higgins ML, Lechevalier HA, Prauser H. | Appl Microbiol | 10.1128/am.19.3.527-533.1970 | 1970 | |
| Metabolism | Mycobacterial lipids: selected topics. | Goren MB. | Bacteriol Rev | 10.1128/br.36.1.33-64.1972 | 1972 | |
| The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages. | Astarie-Dequeker C, N'Diaye EN, Le Cabec V, Rittig MG, Prandi J, Maridonneau-Parini I. | Infect Immun | 10.1128/iai.67.2.469-477.1999 | 1999 | ||
| Metabolism | Protein synthesis in Mycobacterium tuberculosis H37Rv and the effect of streptomycin in streptomycin-susceptible and -resistant strains. | Shaila MS, Gopinathan KP, Ramakrishnan T. | Antimicrob Agents Chemother | 10.1128/aac.4.3.205 | 1973 | |
| Pathogenicity | Changing patterns of plasmid-mediated drug resistance during tetracycline therapy. | Moller JK, Bak AL, Stenderup A, Zachariae H, Afzelius H. | Antimicrob Agents Chemother | 10.1128/aac.11.3.388 | 1977 | |
| Metabolism | Intermediary metabolism of mycobacteria. | Ramakrishnan T, Murthy PS, Gopinathan KP. | Bacteriol Rev | 10.1128/br.36.1.65-108.1972 | 1972 | |
| Mycobacteriophage. I. Physicochemical characterization. | SELLES MI, RUNNALS HR. | J Bacteriol | 10.1128/jb.81.3.442-447.1961 | 1961 | ||
| Steroids. 159. Antimicrobial properties of 21,21-dimethoxy progesterone and other progesterone analogues. | CASAS-CAMPILLO C, BALANDRANO D, GALARZA A. | J Bacteriol | 10.1128/jb.81.3.366-375.1961 | 1961 | ||
| Biochemical and morphological characterization of mycobacteriophage R1. | Soloff BL, Rado TA, Henry BE, Bates JH. | J Virol | 10.1128/jvi.25.1.253-262.1978 | 1978 | ||
| Pathogenicity | Susceptibility of mycobacteria to rifampin. | Woodley CL, Kilburn JO, David HL, Silcox VA. | Antimicrob Agents Chemother | 10.1128/aac.2.4.245 | 1972 | |
| Pathogenicity | Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages. | Rastogi N, Labrousse V, Goh KS, De Sousa JP. | Antimicrob Agents Chemother | 10.1128/aac.35.12.2473 | 1991 | |
| Insertion sequences. | Mahillon J, Chandler M. | Microbiol Mol Biol Rev | 10.1128/mmbr.62.3.725-774.1998 | 1998 | ||
| Enzymology | Phytochemistry and biological properties of glabridin. | Simmler C, Pauli GF, Chen SN. | Fitoterapia | 10.1016/j.fitote.2013.07.003 | 2013 | |
| Enzymology | Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction. | Hermans PW, Schuitema AR, Van Soolingen D, Verstynen CP, Bik EM, Thole JE, Kolk AH, van Embden JD. | J Clin Microbiol | 10.1128/jcm.28.6.1204-1213.1990 | 1990 | |
| Epidemiology of infection by nontuberculous mycobacteria. | Falkinham JO. | Clin Microbiol Rev | 10.1128/cmr.9.2.177 | 1996 | ||
| Pathogenicity | Effects of ethanol on the Escherichia coli plasma membrane. | Dombek KM, Ingram LO. | J Bacteriol | 10.1128/jb.157.1.233-239.1984 | 1984 | |
| Mycobacterium. | Barksdale L, Kim KS. | Bacteriol Rev | 10.1128/br.41.1.217-372.1977 | 1977 | ||
| Interrupted coding sequences in Mycobacterium smegmatis: authentic mutations or sequencing errors? | Deshayes C, Perrodou E, Gallien S, Euphrasie D, Schaeffer C, Van-Dorsselaer A, Poch O, Lecompte O, Reyrat JM. | Genome Biol | 10.1186/gb-2007-8-2-r20 | 2007 | ||
| Metabolism | Elaboration of vomitoxin and zearalenone by Fusarium isolates and the biological activity of Fusarium-produced toxins. | Vesonder RF, Ellis JJ, Rohwedder WK. | Appl Environ Microbiol | 10.1128/aem.42.6.1132-1134.1981 | 1981 | |
| A Review of Sponge-Derived Diterpenes: 2009-2022. | Xia J, Chen X, Li G, Qiu P, Wang W, Shao Z. | Mar Drugs | 10.3390/md22100447 | 2024 | ||
| Anti-mycobacterial nucleoside antibiotics from a marine-derived Streptomyces sp. TPU1236A. | Bu YY, Yamazaki H, Ukai K, Namikoshi M. | Mar Drugs | 10.3390/md12126102 | 2014 | ||
| Marine Pyrrole Alkaloids. | Seipp K, Geske L, Opatz T. | Mar Drugs | 10.3390/md19090514 | 2021 | ||
| Discovery and Biosynthesis of Antimicrobial Phenethylamine Alkaloids from the Marine Flavobacterium Tenacibaculum discolor sv11. | Wang L, Linares-Otoya V, Liu Y, Mettal U, Marner M, Armas-Mantilla L, Willbold S, Kurtan T, Linares-Otoya L, Schaberle TF | J Nat Prod | 10.1021/acs.jnatprod.1c01173 | 2022 | ||
| Dehydroabietic Acid Microencapsulation Potential as Biofilm-Mediated Infections Treatment. | Neto I, Dominguez-Martin EM, Ntungwe E, Reis CP, Pesic M, Faustino C, Rijo P | Pharmaceutics | 10.3390/pharmaceutics13060825 | 2021 | ||
| Pathogenicity | Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis. | Lelovic N, Mitachi K, Yang J, Lemieux MR, Ji Y, Kurosu M | J Antibiot (Tokyo) | 10.1038/s41429-020-0320-7 | 2020 | |
| Enzymology | A New Citrinin Derivative from the Indonesian Marine Sponge-Associated Fungus Penicillium citrinum. | Sabdaningsih A, Liu Y, Mettal U, Heep J, Riyanti, Wang L, Cristianawati O, Nuryadi H, Triandala Sibero M, Marner M, Radjasa OK, Sabdono A, Trianto A, Schaberle TF | Mar Drugs | 10.3390/md18040227 | 2020 | |
| Pathogenicity | Mycelial Growth and Antimicrobial Activity of Pleurotus Species (Agaricomycetes). | Castillo TA, Lemos RA, Pereira JRG, Alves JMA, Teixeira MFS | Int J Med Mushrooms | 10.1615/IntJMedMushrooms.2018025477 | 2018 | |
| Pathogenicity | Mycelial Growth and Antimicrobial Activity of Species of Genus Lentinus (Agaricomycetes) from Brazil. | Castillo TA, Pereira JRG, Alves JMA, Teixeira MFS | Int J Med Mushrooms | 10.1615/IntJMedMushrooms.2017024708 | 2017 | |
| In vitro evaluation of antimicrobial features of vasopressors. | Bostan H, Tomak Y, Karaoglu SA, Erdivanli B, Hanci V | Braz J Anesthesiol | 10.1016/j.bjane.2013.02.002 | 2013 | ||
| Pathogenicity | Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique. | Luo X, Pires D, Ainsa JA, Gracia B, Mulhovo S, Duarte A, Anes E, Ferreira MJ | J Ethnopharmacol | 10.1016/j.jep.2011.04.062 | 2011 | |
| Pathogenicity | IS1096-mediated DNA rearrangements play a key role in genome evolution of Mycobacterium smegmatis. | Wang XM, Galamba A, Warner DF, Soetaert K, Merkel JS, Kalai M, Bifani P, Lefevre P, Mizrahi V, Content J | Tuberculosis (Edinb) | 10.1016/j.tube.2008.02.003 | 2008 | |
| Metabolism | Spontaneous transposition of IS1096 or ISMsm3 leads to glycopeptidolipid overproduction and affects surface properties in Mycobacterium smegmatis. | Kocincova D, Singh AK, Beretti JL, Ren H, Euphrasie D, Liu J, Daffe M, Etienne G, Reyrat JM | Tuberculosis (Edinb) | 10.1016/j.tube.2008.02.005 | 2008 | |
| Pathogenicity | Synthesis of caprazamycin analogues and their structure--activity relationship for antibacterial activity. | Hirano S, Ichikawa S, Matsuda A | J Org Chem | 10.1021/jo702264e | 2007 | |
| Metabolism | The cell envelope structure and properties of Mycobacterium smegmatis mc(2)155: is there a clue for the unique transformability of the strain? | Etienne G, Laval F, Villeneuve C, Dinadayala P, Abouwarda A, Zerbib D, Galamba A, Daffe M | Microbiology (Reading) | 10.1099/mic.0.27869-0 | 2005 | |
| Enzymology | Glycine and alanine dehydrogenase activities are catalyzed by the same protein in Mycobacterium smegmatis: upregulation of both activities under microaerophilic adaptation. | Usha V, Jayaraman R, Toro JC, Hoffner SE, Das KS | Can J Microbiol | 10.1139/w01-126 | 2002 | |
| Phylogeny | [Properties of MTPN11 mycobacteriophage]. | Zhilenkov EL, Shemiakin IG, Stepanshina VN, Korobova OV, Oborotov MV, Dorozhkova IR | Mikrobiologiia | 1998 | ||
| Metabolism | Exochelin genes in Mycobacterium smegmatis: identification of an ABC transporter and two non-ribosomal peptide synthetase genes. | Zhu W, Arceneaux JE, Beggs ML, Byers BR, Eisenach KD, Lundrigan MD | Mol Microbiol | 10.1046/j.1365-2958.1998.00961.x | 1998 | |
| Enzymology | Ca2+/calmodulin dependent protein kinase from Mycobacterium smegmatis ATCC 607. | Sharma S, Giri S, Khuller GK | Mol Cell Biochem | 10.1023/a:1006883006402 | 1998 | |
| Metabolism | Enhanced hydrogen peroxide sensitivity and altered stress protein expression in iron-starved Mycobacterium smegmatis. | Lundrigan MD, Arceneaux JE, Zhu W, Byers BR | Biometals | 10.1023/a:1018355928990 | 1997 | |
| Pathogenicity | Role of cyclic adenosine monophosphate in phospholipid synthesis in Mycobacterium smegmatis ATCC 607. | Kaur H, Khuller GK | Lipids | 10.1007/BF02536043 | 1995 | |
| Pathogenicity | Synthesis of some hydroxamic acid derivatives of benzimidazole and their antibacterial and antifungal activities. | Gunes HS, Cosar G | Arzneimittelforschung | 1992 | ||
| Metabolism | Effect of ethambutol on the phospholipids of ethambutol susceptible and resistant strains of Mycobacterium smegmatis ATCC 607. | Sareen M, Khuller GK | Indian J Biochem Biophys | 1990 | ||
| Pathogenicity | Mode of action of deoxypheganomycin D on Mycobacterium smegmatis ATCC 607. | Suzukake-Tsuchiya K, Hori M, Shimada N, Hamada M | J Antibiot (Tokyo) | 10.7164/antibiotics.41.675 | 1988 | |
| Pathogenicity | On the possibility of cross-resistance between rifampicin and clofazimine in mycobacteria--a laboratory study. | Urbanczik R | Zentralbl Bakteriol Mikrobiol Hyg A | 10.1016/s0176-6724(85)80106-1 | 1985 | |
| Metabolism | Cerulenin inhibition of lipid synthesis and its reversal by exogenous fatty acids in Mycobacterium smegmatis ATCC 607. | Mahajan S, Khuller GK | Can J Biochem Cell Biol | 10.1139/o85-012 | 1985 | |
| Metabolism | Cerulenin effect on phospholipid metabolism in Mycobacterium smegmatis ATCC 607. | Mahajan S, Khuller GK | Biochim Biophys Acta | 10.1016/0005-2760(84)90178-4 | 1984 | |
| Metabolism | Macromolecular biosynthesis in Mycobacterium smegmatis ATCC 607 in the presence of antibodies to mannophosphoinositides. | Khuller GK, Dogra A, Malik U, Asotra S | J Gen Microbiol | 10.1099/00221287-130-7-1795 | 1984 | |
| Phylogeny | Isolation of mycobacterial phage from the laboratory strain Mycobacterium leprae murium "Douglas". | Sula L, Sulova J, Matejka M, Malkova J | Czech Med | 1984 | ||
| Metabolism | Subcellular distribution of mannophosphoinositides in Mycobacterium smegmatis during growth. | Penumarti N, Khuller GK | Experientia | 10.1007/BF01990417 | 1983 | |
| Enzymology | Structural elucidation by field desorption and electron-impact mass spectrometry of the C-mycosides isolated from Mycobacterium smegmatis. | Daffe M, Laneelle MA, Puzo G | Biochim Biophys Acta | 10.1016/0005-2760(83)90304-1 | 1983 | |
| Cultivation | Effect of fatty acid supplementation on the lipid composition of Mycobacterium smegmatis ATCC 607, grown at 27 degrees and 37 degrees C. | Khuller GK, Taneja R, Nath N | J Appl Bacteriol | 10.1111/j.1365-2672.1983.tb01301.x | 1983 | |
| Metabolism | Inhibitory activity and mode of action of diaminodiphenylsulfone in cell-free folate-synthesizing systems prepared from Mycobacterium lufu and Mycobacterium leprae. A comparison. | Kulkarni VM, Seydel JK | Chemotherapy | 10.1159/000238174 | 1983 | |
| Metabolism | Influence of antibodies to mannophosphoinositides on phospholipid synthesis in Mycobacterium smegmatis ATCC 607. | Penumarti N, Khuller GK | Infect Immun | 10.1128/iai.37.3.884-890.1982 | 1982 | |
| Metabolism | Biosynthesis of hexamannophosphoinositides in Mycobacterium smegmatis ATCC 607. | Nalini P, Khuller GK | Arch Microbiol | 10.1007/BF00690824 | 1982 | |
| Pathogenicity | Correlations between structure and antimycobacterial activity in a series of 2-acetylpyridine thiosemicarbazones. | Collins FM, Klayman DL, Morrison NE | J Gen Microbiol | 10.1099/00221287-128-6-1349 | 1982 | |
| Light-induced changes in the phospholipid composition of Mycobacterium smegmatis ATCC 607. | Subramoniam A, Subrahmanyam D | J Gen Microbiol | 10.1099/00221287-128-2-419 | 1982 | ||
| Metabolism | Evidence for plasmid-mediated restriction-modification in Mycobacterium avium intracellulare. | Crawford JT, Cave MD, Bates JH | J Gen Microbiol | 10.1099/00221287-127-2-333 | 1981 | |
| Pathogenicity | Biochemical study of R-75-1, a new semi-synthetic rifamycin. | Xiao-Chang F, Uehara Y, Abe Y, Hori M, Hamada M, Umezawa H | J Antibiot (Tokyo) | 10.7164/antibiotics.34.713 | 1981 | |
| Metabolism | Effect of glycine on phospholipids of Mycobacterium smegmatis ATCC 607. | Subramoniam A, Subrahmanyam D | J Gen Microbiol | 10.1099/00221287-124-1-203 | 1981 | |
| Metabolism | Phospholipid metabolism in Mycobacterium smegmatis ATCC 607 grown at 37 degrees and 27 C degrees C. | Taneja R, Khuller GK | Arch Microbiol | 10.1007/BF00417185 | 1981 | |
| Metabolism | Effect of growth temperature on the lipid composition of Mycobacterium smegmatis ATCC 607. | Taneja R, Malik U, Khuller GK | J Gen Microbiol | 10.1099/00221287-113-2-413 | 1979 | |
| Pathogenicity | Resistance relationships in Mycobacterium smegmatis ATCC 607 to phages sensitive or resistant to both chloroform and streptomycin sulphate. | Jones WD Jr, Greenberg J | J Gen Virol | 10.1099/0022-1317-39-3-555 | 1978 | |
| Pathogenicity | Antitubercular 2,8-bis(alkylaminomethyl)phenazines. | Murdock KC, Lin Y, Thomas JP, Lang SA Jr | J Med Chem | 10.1021/jm00202a020 | 1978 | |
| Pathogenicity | In vitro cytotoxicity of peritoneal macrophages activated with Mycobacterium smegmatis. | Yamamoto S, Tokunaga T | Microbiol Immunol | 10.1111/j.1348-0421.1978.tb00345.x | 1978 | |
| Metabolism | Permeability barrier to rifampin in mycobacteria. | Hui J, Gordon N, Kajioka R | Antimicrob Agents Chemother | 10.1128/AAC.11.5.773 | 1977 | |
| Enzymology | Enzymatic synthesis of 2-O-alpha-D-mannopyranosyl-methyl-alpha-D-mannopyranoside by a cell-free particulate system of Mycobacterium smegmatis. | Schultz JC, Takayama K | Biochim Biophys Acta | 10.1016/0304-4165(76)90184-7 | 1976 | |
| Metabolism | Evidence for host-dependent modification and restriction of bacteriophage DNA in Mycobacterium tuberculosis. | Rado TA, Bates JH, Fitzhugh JK | J Gen Virol | 10.1099/0022-1317-30-1-91 | 1976 | |
| Phylogeny | Nature of the receptor substance of Mycobacterium smegmatis for D4 bacteriophage adsorption. | Furuchi A, Tokunaga T | J Bacteriol | 10.1128/jb.111.2.404-411.1972 | 1972 | |
| Phylogeny | Seven New Alkaloids Isolated from Marine Flavobacterium Tenacibaculum discolor sv11. | Wang L, Marner M, Mettal U, Liu Y, Schaberle TF | Mar Drugs | 10.3390/md20100620 | 2022 |
| #11040 | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 43465 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #20218 | Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 ) |
| #36869 | ; Curators of the CIP; |
| #67770 | Japan Collection of Microorganism (JCM) ; Curators of the JCM; |
| #68382 | Automatically annotated from API zym . |
| #122644 | Collection of Institut Pasteur ; Curators of the CIP; CIP 110083 |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive8319.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data